The 6th SIMPAR Congress is the framework for the IBSA symopsium "Talking about NSAIDs: there is still room to innovate? Focus on diclofenac". Chaired by Prof. Massimo Allegri, President of the Congress, important top figures from the UK are Prof. Kim D. Rainsford who looks into the safety and CV risks, while Prof. Thomas Dietrich explains how the answer to an important need has at last been met thanks to the new low dose of diclofenac for fast and safe subcutaneous administration. Finally, Prof. Guido Fanelli, from Italy, presents an important survey on NSAIDs.
The 6th SIMPAR Congress is the framework for the IBSA symopsium "Talking about NSAIDs: there is still room to innovate? Focus on diclofenac". Chaired by Prof. Massimo Allegri, President of the Congress, important top figures from the UK are Prof. Kim D. Rainsford who looks into the safety and CV risks, while Prof. Thomas Dietrich explains how the answer to an important need has at last been met thanks to the new low dose of diclofenac for fast and safe subcutaneous administration. Finally, Prof. Guido Fanelli, from Italy, presents an important survey on NSAIDs.
interviews by the specialists
Increased pain control and greater safety profile
Now available a new parenteral formulation of diclofenac
Proper use of these drugs
